Kawasaki disease: Medical therapies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Kawasaki disease: Medical therapies

Published:2017-06-05 Issue:5 Volume:12 Page:641-643
ISSN:1747-079X
Container-title:Congenital Heart Disease
language:en
Short-container-title:Congenital Heart Disease

Author:

Newburger Jane W.¹

Affiliation:

1. Department of Cardiology, Boston Children's Hospital, Department of Pediatrics, Harvard Medical School; Boston Massachusetts

Publisher

Computers, Materials and Continua (Tech Science Press)

Subject

Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging,General Medicine,Surgery,Pediatrics, Perinatology and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/chd.12502/fullpdf

Reference10 articles.

1. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association;Newburger;Circulation.,2004

2. Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose;Terai;J Pediatr.,1997

3. Efficacy of intravenous immunoglobulin combined with prednisolone following resistance to initial intravenous immunoglobulin treatment of acute Kawasaki disease;Kobayashi;J Pediatr.,2013

4. Infliximab for intravenous immunoglobulin resistance in Kawasaki disease: a retrospective study;Son;J Pediatr.,2011

5. Prospective open-label trial of etanercept as adjunctive therapy for Kawasaki disease;Choueiter;J Pediatr.,2010

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LncRNAs in Kawasaki disease and Henoch-Schönlein purpura: mechanisms and clinical applications;Molecular and Cellular Biochemistry;2023-08-28

2. International consensus recommendations for management of new onset refractory status epilepticus including febrile infection‐related epilepsy syndrome: Statements and supporting evidence;Epilepsia;2022-09-27

3. Predictors for Intravenous Immunoglobulin Resistance in Patients with Kawasaki Disease;International Journal of Clinical Practice;2022-08-03

4. Stress Ulcer Prophylaxis for Critical Asthma;Pediatrics;2022-03-01

5. A Retrospective Cohort Study of Intravenous Immunoglobulin Therapy in the Acute Phase of Kawasaki Disease: The Earlier, the Better?;Cardiovascular Therapeutics;2021-06-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3